AtriCure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AtriCure and other ETFs, options, and stocks.

About ATRC

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. 

CEO
Michael H. Carrel
CEOMichael H. Carrel
Employees
1,300
Employees1,300
Headquarters
Mason, Ohio
HeadquartersMason, Ohio
Founded
1994
Founded1994
Employees
1,300
Employees1,300

ATRC Key Statistics

Market cap
1.95B
Market cap1.95B
Price-Earnings ratio
-64.56
Price-Earnings ratio-64.56
Dividend yield
Dividend yield
Average volume
574.94K
Average volume574.94K
High today
$39.73
High today$39.73
Low today
$36.38
Low today$36.38
Open price
$36.38
Open price$36.38
Volume
1.00M
Volume1.00M
52 Week high
$43.11
52 Week high$43.11
52 Week low
$28.29
52 Week low$28.29

Stock Snapshot

As of today, AtriCure(ATRC) shares are valued at $38.49. The company's market cap stands at 1.95B, with a P/E ratio of -64.56.

On 2025-12-04, AtriCure(ATRC) stock traded between a low of $36.38 and a high of $39.73. Shares are currently priced at $38.49, which is +5.8% above the low and -3.1% below the high.

The AtriCure(ATRC)'s current trading volume is 1M, compared to an average daily volume of 574.94K.

In the last year, AtriCure(ATRC) shares hit a 52-week high of $43.11 and a 52-week low of $28.29.

In the last year, AtriCure(ATRC) shares hit a 52-week high of $43.11 and a 52-week low of $28.29.

ATRC News

Simply Wall St 5h
Did AtriCure’s Earnings Beat and Insider Selling Just Reframe Its Growth Story?

AtriCure recently reported quarterly results that surpassed analyst earnings expectations, while disclosures showed some directors reducing their holdings throu...

Did AtriCure’s Earnings Beat and Insider Selling Just Reframe Its Growth Story?
Nasdaq 5d
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?

Key Points AtriCure Board of Directors member Sven Wehrwein sold 10,000 shares in the company on Nov. 24 and 25, 2025. The transaction was valued at nearly $3...

Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ATRC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.